CN110638881A - External composition for treating bone diseases and preparation method thereof - Google Patents
External composition for treating bone diseases and preparation method thereof Download PDFInfo
- Publication number
- CN110638881A CN110638881A CN201910993805.3A CN201910993805A CN110638881A CN 110638881 A CN110638881 A CN 110638881A CN 201910993805 A CN201910993805 A CN 201910993805A CN 110638881 A CN110638881 A CN 110638881A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- composition
- frankincense
- myrrh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an external composition for treating osteopathy and a preparation method thereof, wherein the composition is prepared from the following raw material medicines in parts by weight: 18-25 parts of angelica sinensis, 8-13 parts of safflower, 14-18 parts of ligusticum wallichii, 18-25 parts of rhizoma drynariae, 18-25 parts of radix clematidis, 18-25 parts of astragalus membranaceus, 18-25 parts of radix puerariae, 18-25 parts of pseudo-ginseng, 18-25 parts of rhizoma corydalis, 3-8 parts of frankincense, 3-8 parts of myrrh, 3-8 parts of borneol, 14-18 parts of paniculate swallowwort root, 4-10 parts of camphor, 8-13 parts of radix aconiti and 15-20 parts of eucommia ulmoides; the preparation method comprises the following steps: mixing all the raw materials, soaking for 2-4 hr, decocting with strong fire for 3-5 hr, concentrating supernatant, adding matrix, and making into unguent. The invention has the characteristics of relieving pain and swelling, improving symptoms quickly, having high cure rate and low recurrence rate after healing for various osteopathia caused by wind, cold and dampness.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to an external composition for treating bone diseases and a preparation method thereof.
Background
Rheumatism is mainly caused by poor blood circulation caused by wind cold, and the diseases are caused by poor nutrition supply of muscles, ligaments, bursa and fascia. The rheumatic bone disease is a chronic systemic disease which is lingering and difficult to heal, the disease starts slowly at the beginning, and the symptoms of the patient such as tiredness and hypodynamia, weight loss, poor appetite, low fever, numbness and stabbing pain of hands and feet and the like are caused from the beginning. Later on, symptoms such as joint pain, stiffness, swelling of the surrounding skin, hot flashes, pain caused by automatic and passive movements occur. Many joints of a patient are affected, then arthritis, joint stiffness, distending pain and the like are developed, the patient is easy to have fever, accelerated pulse, anemia and joint deformity along with the aggravation of the disease of the patient with the rheumatic bone disease, and even serious patients influence the normal life, so the life is greatly afflicted.
Currently, the treatment of rheumatoid bone diseases includes traditional Chinese medicine treatment and western medicine treatment. Wherein, the western medicine treatment comprises drug treatment, physical treatment, surgical treatment, rehabilitation treatment, special treatment and the like. The western medicine treatment often has operation pain, can not cure radically and is easy to relapse, and the western medicine has great harm to the body and is easy to cause influence on the body health after long-term use. On the contrary, the traditional Chinese medicine treatment includes two categories of strengthening the body resistance and eliminating the pathogenic factors, wherein the strengthening method is mainly used for adjusting the physiological functions of yin and yang, qi and blood and viscera of the patient and enhancing the immunity and disease resistance of the organism of the patient; the pathogenic factors expelling method is mainly to adopt symptomatic treatment methods of clearing away heat and toxic materials, dispelling wind, removing dampness and dispelling cold according to the excess of exogenous pathogenic factors such as wind, cold and dampness and the difference of symptoms of patients. However, clinical data statistics show that the traditional Chinese medicine treatment method for the patients with the rheumatoid bone diseases in the existing treatment scheme can only radically cure a few patients, and only has the effects of relieving symptoms and controlling the disease conditions for most patients.
At present, no traditional Chinese medicine composition with good effect is available for treating the rheumatoid bone diseases.
Disclosure of Invention
In order to solve the problems in the prior art, the invention aims to provide an external composition for treating bone diseases and a preparation method thereof.
The technical scheme adopted by the invention is as follows:
an external composition for treating osteopathy comprises the following raw material medicines in parts by weight: 18-25 parts of angelica, 8-13 parts of safflower, 14-18 parts of ligusticum wallichii, 18-25 parts of drynaria rhizome, 18-25 parts of clematis root, 18-25 parts of astragalus membranaceus, 18-25 parts of kudzu root, 18-25 parts of pseudo-ginseng, 18-25 parts of corydalis tuber, 3-8 parts of frankincense, 3-8 parts of myrrh, 3-8 parts of borneol, 14-18 parts of paniculate swallowwort root, 4-10 parts of camphor, 8-13 parts of monkshood and 15-20 parts of eucommia bark.
Further, the composition is prepared from the following raw material medicines in parts by weight: 20 parts of angelica sinensis, 12 parts of safflower, 15 parts of ligusticum wallichii, 20 parts of rhizoma drynariae, 20 parts of radix clematidis, 20 parts of astragalus mongholicus, 20 parts of radix puerariae, 20 parts of pseudo-ginseng, 20 parts of rhizoma corydalis, 5 parts of frankincense, 5 parts of myrrh, 5 parts of borneol, 15 parts of paniculate swallowwort root, 6 parts of camphor, 12 parts of radix aconiti and 18 parts of eucommia ulmoides.
Further, the composition is prepared from the following raw material medicines in parts by weight: 18 parts of angelica, 8 parts of safflower, 14 parts of ligusticum wallichii, 18 parts of rhizoma drynariae, 18 parts of radix clematidis, 18 parts of astragalus mongholicus, 18 parts of radix puerariae, 18 parts of pseudo-ginseng, 18 parts of rhizoma corydalis, 3 parts of frankincense, 3 parts of myrrh, 3 parts of borneol, 14 parts of paniculate swallowwort root, 4 parts of camphor, 8 parts of radix aconiti and 15 parts of eucommia ulmoides.
Further, the composition is prepared from the following raw material medicines in parts by weight: 25 parts of angelica, 13 parts of safflower, 18 parts of ligusticum wallichii, 25 parts of rhizoma drynariae, 25 parts of radix clematidis, 25 parts of astragalus mongholicus, 25 parts of radix puerariae, 25 parts of pseudo-ginseng, 25 parts of rhizoma corydalis, 8 parts of frankincense, 8 parts of myrrh, 8 parts of borneol, 18 parts of paniculate swallowwort root, 10 parts of camphor, 13 parts of radix aconiti and 20 parts of eucommia ulmoides.
Further, the composition is prepared from the following raw material medicines in parts by weight: 18 parts of angelica, 8 parts of safflower, 14 parts of ligusticum wallichii, 18 parts of rhizoma drynariae, 18 parts of radix clematidis, 25 parts of astragalus mongholicus, 25 parts of radix puerariae, 25 parts of pseudo-ginseng, 25 parts of rhizoma corydalis, 8 parts of frankincense, 8 parts of myrrh, 8 parts of borneol, 18 parts of paniculate swallowwort root, 10 parts of camphor, 13 parts of radix aconiti and 20 parts of eucommia ulmoides.
Further, the composition is prepared from the following raw material medicines in parts by weight: 25 parts of angelica, 13 parts of safflower, 18 parts of ligusticum wallichii, 25 parts of rhizoma drynariae, 25 parts of radix clematidis, 18 parts of astragalus mongholicus, 18 parts of radix puerariae, 18 parts of pseudo-ginseng, 18 parts of rhizoma corydalis, 3 parts of frankincense, 3 parts of myrrh, 3 parts of borneol, 14 parts of paniculate swallowwort root, 4 parts of camphor, 8 parts of radix aconiti and 15 parts of eucommia ulmoides.
Further, the composition is in the form of spray, paste or powder.
A method for preparing a composition for external use for treating bone diseases, comprising the steps of: mixing all the raw materials, soaking for 2-4 hr, decocting with strong fire for 3-5 hr, concentrating supernatant, adding matrix, and making into unguent.
The invention has the beneficial effects that: according to the external composition for treating bone diseases and the preparation method, the Chinese angelica, the safflower, the ligusticum wallichii, the rhizoma drynariae, the radix clematidis, the astragalus mongholicus, the root of kudzu vine, the pseudo-ginseng, the rhizoma corydalis, the frankincense, the myrrh, the borneol, the paniculate swallowwort root, the camphor, the radix aconiti and the eucommia bark have the effects of activating blood circulation to dredge collaterals, regulating ying and strengthening defensive qi, tonifying the kidney and strengthening bones, and dispelling cold and relieving pain; the invention is used by being prepared into paste, has better curative effect on bone diseases such as degenerative change of bone joints, hyperosteogeny, rheumatic and rheumatoid arthritis, traumatic injury and the like caused by wind, cold and dampness; therefore, the invention has the characteristics of relieving pain and swelling, improving symptoms quickly, having high cure rate and low recurrence rate after healing.
Detailed Description
The present invention is further illustrated below with reference to specific examples.
A Chinese medicinal composition
An external composition for treating osteopathy comprises the following raw material medicines in parts by weight: 18-25 parts of angelica, 8-13 parts of safflower, 14-18 parts of ligusticum wallichii, 18-25 parts of drynaria rhizome, 18-25 parts of clematis root, 18-25 parts of astragalus membranaceus, 18-25 parts of kudzu root, 18-25 parts of pseudo-ginseng, 18-25 parts of corydalis tuber, 3-8 parts of frankincense, 3-8 parts of myrrh, 3-8 parts of borneol, 14-18 parts of paniculate swallowwort root, 4-10 parts of camphor, 8-13 parts of monkshood and 15-20 parts of eucommia bark.
Further, the optimized composition is as follows:
an external composition for treating osteopathy comprises the following raw material medicines in parts by weight: 20 parts of angelica sinensis, 12 parts of safflower, 15 parts of ligusticum wallichii, 20 parts of rhizoma drynariae, 20 parts of radix clematidis, 20 parts of astragalus mongholicus, 20 parts of radix puerariae, 20 parts of pseudo-ginseng, 20 parts of rhizoma corydalis, 5 parts of frankincense, 5 parts of myrrh, 5 parts of borneol, 15 parts of paniculate swallowwort root, 6 parts of camphor, 12 parts of radix aconiti and 18 parts of eucommia ulmoides.
Second, preparation method
The external composition of the invention is prepared into external dosage forms such as spray, paste or powder.
Or the composition of the invention is prepared into paste according to the following method for use.
A method for preparing a composition for external use for treating bone diseases, comprising the steps of: mixing all the raw materials, soaking for 2-4 hr, decocting with strong fire for 3-5 hr, concentrating supernatant, adding matrix, and making into unguent.
Third, the indications function
The invention is suitable for bone diseases such as bone joint degenerative change, hyperosteogeny, rheumatic and rheumatoid arthritis, traumatic injury and the like caused by wind, cold and dampness; is suitable for treating pain caused by bone spur, cervical vertebra, lumbar vertebra, degenerative change of bone joint, and hydrops, and has repercussive and analgesic effects on rheumatism, rheumatoid diseases, and traumatic injury.
Fourth, clinical conditions
960 people with cervical spondylosis, lumbar spondylosis, osteoarticular hyperplasia and knee joint effusion are treated in ten years, the treatment course is generally different from 3 to 8 according to different disease conditions, 610 people are cured, the symptoms are obviously relieved for 280 people, and the symptoms are improved for 56 people; treating rheumatic arthritis 580 people, and curing 536 people; 120 people with rheumatoid arthritis are treated, and 92 people with symptoms are improved; the traumatic injury can be cured by more than 700 persons generally for 3-5 times, and the effective rate is more than 90%.
The use method comprises the following steps: the patch is taken down after being cleaned locally for 48-72 hours, and replaced by a new patch, 6 patches is a course of treatment. The specification is 12cm by 12 cm.
Fifth, example
Example 1
An external composition for treating osteopathy comprises the following raw material medicines in parts by weight: 18 parts of angelica, 8 parts of safflower, 14 parts of ligusticum wallichii, 18 parts of rhizoma drynariae, 18 parts of radix clematidis, 18 parts of astragalus mongholicus, 18 parts of radix puerariae, 19 parts of pseudo-ginseng, 18 parts of rhizoma corydalis, 6 parts of frankincense, 6 parts of myrrh, 3 parts of borneol, 14 parts of paniculate swallowwort root, 4 parts of camphor, 8 parts of radix aconiti and 17 parts of eucommia ulmoides.
The composition can be spray, paste or powder.
Example 2
An external composition for treating osteopathy comprises the following raw material medicines in parts by weight: 25 parts of angelica, 13 parts of safflower, 18 parts of ligusticum wallichii, 23 parts of rhizoma drynariae, 25 parts of radix clematidis, 25 parts of astragalus mongholicus, 25 parts of radix puerariae, 25 parts of pseudo-ginseng, 23 parts of rhizoma corydalis, 8 parts of frankincense, 8 parts of myrrh, 8 parts of borneol, 18 parts of paniculate swallowwort root, 10 parts of camphor, 13 parts of radix aconiti and 16 parts of eucommia ulmoides.
The composition can be spray, paste or powder.
Example 3
An external composition for treating osteopathy comprises the following raw material medicines in parts by weight: 18-25 parts of angelica, 11 parts of safflower, 15 parts of ligusticum wallichii, 19 parts of drynaria rhizome, 21 parts of radix clematidis, 22 parts of astragalus mongholicus, 22 parts of radix puerariae, 20 parts of pseudo-ginseng, 24 parts of corydalis tuber, 5 parts of frankincense, 5 parts of myrrh, 6 parts of borneol, 15 parts of paniculate swallowwort root, 8 parts of camphor, 10 parts of radix aconiti and 18 parts of eucommia ulmoides.
The composition can be spray, paste or powder.
Example 4
An external composition for treating osteopathy comprises the following raw material medicines in parts by weight: 20 parts of angelica sinensis, 12 parts of safflower, 15 parts of ligusticum wallichii, 20 parts of rhizoma drynariae, 20 parts of radix clematidis, 20 parts of astragalus mongholicus, 20 parts of radix puerariae, 20 parts of pseudo-ginseng, 20 parts of rhizoma corydalis, 5 parts of frankincense, 5 parts of myrrh, 5 parts of borneol, 15 parts of paniculate swallowwort root, 6 parts of camphor, 12 parts of radix aconiti and 18 parts of eucommia ulmoides.
A method for preparing a composition for external use for treating bone diseases, comprising the steps of: mixing all the raw materials, soaking for 3 hr, decocting with strong fire for 4 hr, concentrating the supernatant, adding matrix, and making into unguent.
Example 5
An external composition for treating osteopathy comprises the following raw material medicines in parts by weight: 18 parts of angelica, 8 parts of safflower, 14 parts of ligusticum wallichii, 18 parts of rhizoma drynariae, 18 parts of radix clematidis, 18 parts of astragalus mongholicus, 18 parts of radix puerariae, 18 parts of pseudo-ginseng, 18 parts of rhizoma corydalis, 3 parts of frankincense, 3 parts of myrrh, 3 parts of borneol, 14 parts of paniculate swallowwort root, 4 parts of camphor, 8 parts of radix aconiti and 15 parts of eucommia ulmoides.
A method for preparing a composition for external use for treating bone diseases, comprising the steps of: mixing all the raw materials, soaking for 2 hr, decocting with strong fire for 3 hr, concentrating the supernatant, adding matrix, and making into unguent.
Example 6
An external composition for treating osteopathy comprises the following raw material medicines in parts by weight: 25 parts of angelica, 13 parts of safflower, 18 parts of ligusticum wallichii, 25 parts of rhizoma drynariae, 25 parts of radix clematidis, 25 parts of astragalus mongholicus, 25 parts of radix puerariae, 25 parts of pseudo-ginseng, 25 parts of rhizoma corydalis, 8 parts of frankincense, 8 parts of myrrh, 8 parts of borneol, 18 parts of paniculate swallowwort root, 10 parts of camphor, 13 parts of radix aconiti and 20 parts of eucommia ulmoides.
A method for preparing a composition for external use for treating bone diseases, comprising the steps of: mixing all the raw materials, soaking for 4 hr, decocting with strong fire for 5 hr, concentrating the supernatant, adding matrix, and making into unguent.
Example 7
An external composition for treating osteopathy comprises the following raw material medicines in parts by weight: 18 parts of angelica, 8 parts of safflower, 14 parts of ligusticum wallichii, 18 parts of rhizoma drynariae, 18 parts of radix clematidis, 25 parts of astragalus mongholicus, 25 parts of radix puerariae, 25 parts of pseudo-ginseng, 25 parts of rhizoma corydalis, 8 parts of frankincense, 8 parts of myrrh, 8 parts of borneol, 18 parts of paniculate swallowwort root, 10 parts of camphor, 13 parts of radix aconiti and 20 parts of eucommia ulmoides.
A method for preparing a composition for external use for treating bone diseases, comprising the steps of: mixing all the raw materials, soaking for 3 hr, decocting with strong fire for 4 hr, concentrating the supernatant, adding matrix, and making into unguent.
Example 8
An external composition for treating osteopathy comprises the following raw material medicines in parts by weight: 25 parts of angelica, 13 parts of safflower, 18 parts of ligusticum wallichii, 25 parts of rhizoma drynariae, 25 parts of radix clematidis, 18 parts of astragalus mongholicus, 18 parts of radix puerariae, 18 parts of pseudo-ginseng, 18 parts of rhizoma corydalis, 3 parts of frankincense, 3 parts of myrrh, 3 parts of borneol, 14 parts of paniculate swallowwort root, 4 parts of camphor, 8 parts of radix aconiti and 15 parts of eucommia ulmoides.
A method for preparing a composition for external use for treating bone diseases, comprising the steps of: mixing all the raw materials, soaking for 3 hr, decocting with strong fire for 4 hr, concentrating the supernatant, adding matrix, and making into unguent.
The present invention is not limited to the above-described alternative embodiments, and various other forms of products can be obtained by anyone in light of the present invention. The above detailed description should not be taken as limiting the scope of the invention, which is defined in the claims, and which the description is intended to be interpreted accordingly.
Claims (8)
1. A topical composition for treating bone disorders, comprising: the traditional Chinese medicine composition is composed of the following raw material medicines in parts by weight: 18-25 parts of angelica, 8-13 parts of safflower, 14-18 parts of ligusticum wallichii, 18-25 parts of drynaria rhizome, 18-25 parts of clematis root, 18-25 parts of astragalus membranaceus, 18-25 parts of kudzu root, 18-25 parts of pseudo-ginseng, 18-25 parts of corydalis tuber, 3-8 parts of frankincense, 3-8 parts of myrrh, 3-8 parts of borneol, 14-18 parts of paniculate swallowwort root, 4-10 parts of camphor, 8-13 parts of monkshood and 15-20 parts of eucommia bark.
2. The topical composition for the treatment of bone disease as claimed in claim 1, wherein: the traditional Chinese medicine composition is composed of the following raw material medicines in parts by weight: 20 parts of angelica sinensis, 12 parts of safflower, 15 parts of ligusticum wallichii, 20 parts of rhizoma drynariae, 20 parts of radix clematidis, 20 parts of astragalus mongholicus, 20 parts of radix puerariae, 20 parts of pseudo-ginseng, 20 parts of rhizoma corydalis, 5 parts of frankincense, 5 parts of myrrh, 5 parts of borneol, 15 parts of paniculate swallowwort root, 6 parts of camphor, 12 parts of radix aconiti and 18 parts of eucommia ulmoides.
3. The topical composition for the treatment of bone disease as claimed in claim 1, wherein: the traditional Chinese medicine composition is composed of the following raw material medicines in parts by weight: 18 parts of angelica, 8 parts of safflower, 14 parts of ligusticum wallichii, 18 parts of rhizoma drynariae, 18 parts of radix clematidis, 18 parts of astragalus mongholicus, 18 parts of radix puerariae, 18 parts of pseudo-ginseng, 18 parts of rhizoma corydalis, 3 parts of frankincense, 3 parts of myrrh, 3 parts of borneol, 14 parts of paniculate swallowwort root, 4 parts of camphor, 8 parts of radix aconiti and 15 parts of eucommia ulmoides.
4. The topical composition for the treatment of bone disease as claimed in claim 1, wherein: the traditional Chinese medicine composition is composed of the following raw material medicines in parts by weight: 25 parts of angelica, 13 parts of safflower, 18 parts of ligusticum wallichii, 25 parts of rhizoma drynariae, 25 parts of radix clematidis, 25 parts of astragalus mongholicus, 25 parts of radix puerariae, 25 parts of pseudo-ginseng, 25 parts of rhizoma corydalis, 8 parts of frankincense, 8 parts of myrrh, 8 parts of borneol, 18 parts of paniculate swallowwort root, 10 parts of camphor, 13 parts of radix aconiti and 20 parts of eucommia ulmoides.
5. The topical composition for the treatment of bone disease as claimed in claim 1, wherein: the traditional Chinese medicine composition is composed of the following raw material medicines in parts by weight: 18 parts of angelica, 8 parts of safflower, 14 parts of ligusticum wallichii, 18 parts of rhizoma drynariae, 18 parts of radix clematidis, 25 parts of astragalus mongholicus, 25 parts of radix puerariae, 25 parts of pseudo-ginseng, 25 parts of rhizoma corydalis, 8 parts of frankincense, 8 parts of myrrh, 8 parts of borneol, 18 parts of paniculate swallowwort root, 10 parts of camphor, 13 parts of radix aconiti and 20 parts of eucommia ulmoides.
6. The topical composition for the treatment of bone disease as claimed in claim 1, wherein: the traditional Chinese medicine composition is composed of the following raw material medicines in parts by weight: 25 parts of angelica, 13 parts of safflower, 18 parts of ligusticum wallichii, 25 parts of rhizoma drynariae, 25 parts of radix clematidis, 18 parts of astragalus mongholicus, 18 parts of radix puerariae, 18 parts of pseudo-ginseng, 18 parts of rhizoma corydalis, 3 parts of frankincense, 3 parts of myrrh, 3 parts of borneol, 14 parts of paniculate swallowwort root, 4 parts of camphor, 8 parts of radix aconiti and 15 parts of eucommia ulmoides.
7. The topical composition for the treatment of bone disease as claimed in claim 1, wherein: the composition is in the form of spray, paste or powder.
8. A method for preparing a composition for external use for treating bone disease according to any one of claims 1 to 6, comprising: the method comprises the following steps: mixing all the raw materials, soaking for 2-4 hr, decocting with strong fire for 3-5 hr, concentrating supernatant, adding matrix, and making into unguent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910993805.3A CN110638881A (en) | 2019-10-18 | 2019-10-18 | External composition for treating bone diseases and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910993805.3A CN110638881A (en) | 2019-10-18 | 2019-10-18 | External composition for treating bone diseases and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110638881A true CN110638881A (en) | 2020-01-03 |
Family
ID=68994343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910993805.3A Pending CN110638881A (en) | 2019-10-18 | 2019-10-18 | External composition for treating bone diseases and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110638881A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114259533A (en) * | 2022-02-21 | 2022-04-01 | 巴秀丽 | Composition for treating arthralgia and myalgia |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101167818A (en) * | 2006-10-26 | 2008-04-30 | 杨书楼 | Hyperosteogeny plaster |
| CN105998217A (en) * | 2016-06-27 | 2016-10-12 | 樊继绪 | Traditional Chinese medicine composition for treating cervical spondylosis and preparation method |
-
2019
- 2019-10-18 CN CN201910993805.3A patent/CN110638881A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101167818A (en) * | 2006-10-26 | 2008-04-30 | 杨书楼 | Hyperosteogeny plaster |
| CN105998217A (en) * | 2016-06-27 | 2016-10-12 | 樊继绪 | Traditional Chinese medicine composition for treating cervical spondylosis and preparation method |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114259533A (en) * | 2022-02-21 | 2022-04-01 | 巴秀丽 | Composition for treating arthralgia and myalgia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101773567A (en) | Bone injury ache plaster | |
| CN110638881A (en) | External composition for treating bone diseases and preparation method thereof | |
| CN104225283B (en) | A kind of oral medicinal herb medicine and plaster for treating cervical vertebra, scapulohumeral periarthritis, protrusion of lumber intervertebral disc, rheumatic arthritis and rheumatoid arthritis | |
| CN102274372B (en) | Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage | |
| CN103301430A (en) | Medicament for treating hyperostosis and pain in waist and lower extremities and preparation method thereof | |
| CN103656540A (en) | Traditional Chinese medicine composition and preparation method thereof for treating cervical spondylosis | |
| CN103585294B (en) | A kind of for plaster treating hyperosteogeny and preparation method thereof | |
| CN102764355B (en) | Traditional Chinese medicine composite for curing femoral head necrosis | |
| CN104623617A (en) | Medicine for treating osteoarticular diseases and preparation method and application method of medicine | |
| CN1267127C (en) | Osteoproliferation medicine for external application | |
| CN110538272A (en) | swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof | |
| CN109289020A (en) | Chinese medicine acupoint magnetic heat orients transdermal | |
| CN110538297A (en) | Traditional Chinese medicine composition for treating acute muscle and tendon injury and preparation method thereof | |
| CN110917278A (en) | Externally applied medicine for treating rheumatic ostealgia and preparation method and application thereof | |
| CN103877467A (en) | Traditional Chinese medicinal capsule for treating hyperosteogeny | |
| CN103550446A (en) | Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition | |
| CN103585257A (en) | Traditional Chinese medicine powder for treating fractures | |
| CN103099889B (en) | Traditional Chinese medicine wine for treating lumbar spinal stenosis | |
| CN104645067A (en) | Traditional Chinese medicine for treating gonarthromeningitis by matching with acupuncture and moxibustion | |
| CN106421255A (en) | Topical traditional Chinese composition and its application | |
| CN104324190A (en) | External traditional Chinese medicine for treating mouse hand and preparation method thereof | |
| CN105267324A (en) | Oral traditional Chinese medicine for treating lumbar vertebra hyperosteogeny | |
| CN105853760A (en) | Orthopedic plaster and preparation method thereof | |
| CN104524017A (en) | Traditional Chinese medicine preparation for treating angiitis | |
| CN103784892A (en) | External agentia for treating osteoproliferation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200103 |